Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 3, 2025
PRNewswire
Biotechnology, News

MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move comes...

July 1, 2025
PRNewswire
Biotechnology, Healthcare, News

Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and...

July 1, 2025
Business Wire
Biotechnology, Healthcare, News

Vertex’s ALYFTREK® Approved by European Commission

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have...

July 1, 2025
Business Wire
Artificial Intelligence, Biotechnology, Healthcare, News

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter...

June 30, 2025
PRNewswire
Biotechnology, News

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), recently announced a $90M investment plan to expand two...

June 27, 2025
PRNewswire
Biotechnology, News

Zentiva calls for Pause – Repair – Relaunch of the Urban Wastewater Treatment Directive (UWWTD)

As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels. The conference...

June 27, 2025
PRNewswire
Biotechnology, News

ProBio Opens New U.S. Facility for Plasmid & Viral Vector Manufacturing

The celebration included an open house event featuring a guided site tour, ribbon-cutting ceremony, and a keynote address by Donavon Decker, the first person in the world to receive gene therapy...

June 27, 2025
PRNewswire
Biotechnology, Healthcare, News

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety and efficacy of adjunctive fenfluramine in CDKL5 deficiency disorder (CDD) met its primary and most key...

June 27, 2025
PRNewswire
Biotechnology, News

US GENIUS Act Could Reinvent the Dollar and Secure Crypto Leadership: Bybit–Block Scholes Report

Bybit, the world’s second-largest cryptocurrency exchange by trading volume, today released a new crypto insights report with Block Scholes, revealing how landmark U.S. legislative proposals like the GENIUS Act are set to reinforce the U.S. dollar’s global...

June 26, 2025
Business Wire
Biotechnology, News

KalVista Secures Canadian Licensing Deal with Pendopharm for Sebetralstat in HAE Market

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that its wholly-owned subsidiary, KalVista Pharmaceuticals, Ltd., has granted Pendopharm, a division of Pharmascience Inc., the exclusive rights to manage the regulatory...